Paper: Double-Blind, Placebo-Controlled Randomized Controlled Trial of Hydroxyurea for HbSC: Results of the Prospective Identification of Variables As Outcomes for Treatment (PIVOT) Trial
Program: Oral and Poster Abstracts Type: Oral Session: Plenary Scientific Session Hematology Disease Topics & Pathways: Research, Clinical trials, Sickle Cell Disease, Clinical Research, Hemoglobinopathies, Diseases Yvonne Dei-Adomakoh, MBBS, FWACP, MWACP 1 *, Catherine I. Segbefia, MBChB 2 *, Teresa S. Latham, MA 3 *, Adam C. Lane, PhD 3 *, Klenam Dzefi-Tettey, MBChB 4 *, Kwesi N. Amissah-Arthur, MBChB 5 *, Oksana Corquaye 6 *, Lyudmyla Korang 6 *, Enoch Mensah 1 *, Priscilla Ekpale 7 *, William K